Table 2 Descriptive data of group 2 and group 3 regarding hypertension, diabetes treatment, and diabetic duration
| Â | Group 2 (diabetic patients without retinopathy) (n=15) | Group 3 (diabetic patients with retinopathy) (n=15) | |||
|---|---|---|---|---|---|
Count | % | Count | % | ||
Hypertension | Yes | 4 | 26.7% | 6 | 40.0% |
No | 11 | 73.3% | 9 | 60.0% | |
Diabetic treatment | Oral treatment | 12 | 80.0% | 9 | 60.0% |
Insulin | 2 | 13.3% | 6 | 40.0% | |
No treatment | 1 | 6.7% | 0 | 0.0% | |
Diabetic duration (years) Median (IQR) |  | 4 (1–12) | 15 (7–20) | ||